Mesalazine
ArticlesMedicine Compliance Aid StabilityLactation Safety Information · Published , updated
86977007
Articles
19 October 2020
What are the differences between different brands of mesalazine tablets?
This updated Medicines Q&A discusses the differences between different brands of mesalazine tablets Summary Asacol MR, Mezavant XL, Octasa MR, Pentasa Slow Release, Salofalk and… Mesalazine
29 September 2020
Suggestions for Therapeutic Drug Monitoring in Adults in Primary Care
This document is intended to support local discussions on how to monitor commonly prescribed high risk medicines in primary care. The monitoring parameters cited… Alfacalcidol Aminophylline Amiodarone Apixaban Aripiprazole Atorvastatin Azathioprine Candesartan Carbamazepine Carbimazole Care homes Celecoxib Ciclosporin Community Health Services Dabigatran etexilate Diclofenac potassium Diclofenac sodium Digoxin Donepezil Dronedarone Edoxaban Enalapril Eplerenone Etoricoxib Furosemide Galantamine Haloperidol Hydrocortisone Hydroxycarbamide Ibuprofen Leflunomide Levothyroxine Lisinopril Lithium Losartan Mental Health Mercaptopurine Mesalazine Methotrexate Monitoring Mycophenolate mofetil Mycophenolic acid Naproxen Nitrofurantoin Olanzapine Penicillamine Perindopril Phenytoin Phenytoin sodium Pioglitazone Pravastatin Prednisone Primary Care Propylthiouracil Quetiapine Ramipril Risperidone Rivaroxaban Rivastigmine Rosuvastatin Simvastatin Sirolimus Sodium valproate Spironolactone Sulfadiazine Tacrolimus Telmisartan Theophylline Transfer of care Trusts Valproic acid Warfarin
21 September 2020
Safety in lactation: Drugs for chronic bowel disorders
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminosalicylates for chronic bowel disorders Mesalazine… Adalimumab Azathioprine Balsalazide Beclometasone Budesonide Ciclosporin Gastrointestinal disorders Golimumab Hydrocortisone Infliximab Mercaptopurine Mesalazine Methotrexate Obstetrics and gynaecology Paediatrics and neonates Prednisolone Safety in Breastfeeding Sulfasalazine Teduglutide Ustekinumab Vedolizumab
14 May 2020
What are the differences between non-oral mesalazine preparations?
This updated Medicines Q&A reviews the differences between the four mesalazine enema products and three brands of mesalazine suppositories that are currently available in the… Mesalazine
23 October 2019
Shortage of salofalk (mesalazine) suppositories (500mg and 1g)
This memo advises on use of Pentasa (mesalazine) 1g suppository as an alternative. Gastrointestinal disorders Mesalazine SupplyMedicine Compliance Aid Stability
Mezavant XLShire Pharmaceuticals Ltd
Shire Pharmaceuticals Ltd
Mezavant XL
Tablets e/c m/r 1.2g
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Airtight container
Protect from light
Store in airtight containers and protect from light. SPC states store in original packaging.
22 October 2015
Asacol MRWarner Chilcott UK Ltd
Warner Chilcott UK Ltd
Asacol MR
Tablets e/c 400mg, 800mg
G1 · Green 1Stability data indicates that the drug is suitable for CAs and there are no theoretical concerns with the product.
Airtight container
Protect from light
If the desiccant is removed, or the tablets are dispensed in alternative packaging without the desiccant, the tablets will be stable for at least six months (or to the expiry date of the original container).
22 October 2015
IpocolSandoz Ltd
Sandoz Ltd
Ipocol
Tablets e/c 400mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Airtight container
Protect from light
Store in airtight containers and protect from light.
29 July 2015
SalofalkDr Falk Pharma UK Ltd
Dr Falk Pharma UK Ltd
Salofalk
Tablets e/c 250mg, 500mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Airtight container
Protect from light
Store in airtight containers and protect from light and moisture.
22 October 2015
PentasaFerring Pharmaceuticals Ltd
Ferring Pharmaceuticals Ltd
Pentasa
Tablets m/r 500mg, 1g
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers and protect from light. Discolouration (which is harmless) may occur outside packaging. Maximum one week in MCA.
22 October 2015
OctasaTillotts Pharma Ltd
Tillotts Pharma Ltd
Octasa
Tablets e/c m/r 400mg, 800mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Airtight container
Protect from light
Store in airtight containers and protect from light. SPC states store in original packaging. Company have stability studies that demonstrate stability in open storage for 30 days
22 October 2015
Lactation Safety Information
-
Synonym: Mesalamine
Moderate amount of published evidence of safety
Mesalazine has been associated with one confirmed and a small number of possible cases of diarrhoea in breastfed infants
Monitor infant for diarrhoea
15 September 2019